{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:37:09Z","timestamp":1747204629648,"version":"3.40.5"},"posted":{"date-parts":[[2023,4,5]]},"group-title":"In Review","reference-count":33,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,3,1]]},"abstract":"<title>Abstract<\/title>\n        <p>Angiotensin-converting enzyme 2 (ACE2) is protective in cardiovascular disease, lung injury and diabetes yet paradoxically underlies our susceptibility to SARs-CoV2 infection and the fatal heart and lung disease it can induce. Furthermore, diabetic patients have chronic, systemic inflammation and altered ACE2 expression resulting in increased risk of severe COVID-19 and the associated mortality. A drug that could increase ACE2 activity and inhibit cellular uptake of severe acute respiratory syndrome coronavirus 2 (SARs-CoV2), thus decrease infection, would be of high relevance to cardiovascular disease, diabetes and SARs-CoV2 infection. While the need for such a drug lead was highlighted over a decade ago receiving over 600 citations,<sup>1<\/sup> to date, no such drugs are available.<sup>2<\/sup> Here, we report the development of a novel ACE2 stimulator, designated \u20182A\u2019(international PCT filed), which is a 10 amino acid peptide derived from a snake venom, and demonstrate its in vitro and in vivo efficacy against SARs-CoV2 infection and associated lung inflammation. Peptide 2A also provides remarkable protection against glycaemic dysregulation, weight loss and disease severity in a mouse model of type 1 diabetes. No untoward effects of 2A were observed in these pre-clinical models suggesting its strong clinical translation potential.<\/p>","DOI":"10.21203\/rs.3.rs-2642181\/v1","type":"posted-content","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T20:17:02Z","timestamp":1680725822000},"source":"Crossref","is-referenced-by-count":0,"title":["Development of a novel angiotensin converting enzyme 2 stimulator with broad implications in SARS-CoV2 infection and type 1 diabetes"],"prefix":"10.21203","author":[{"given":"Haru","family":"Nomura","sequence":"first","affiliation":[{"name":"The University of Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Chemistry and Molecular Biosciences, The University of Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8031-9086","authenticated-orcid":false,"given":"Jiangning","family":"Song","sequence":"additional","affiliation":[{"name":"Monash University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hung","sequence":"additional","affiliation":[{"name":"School of Science, RMIT University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley","family":"Tran","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, The University of Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"TA","sequence":"additional","affiliation":[{"name":"Griffith University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahima","family":"Akther","sequence":"additional","affiliation":[{"name":"Griffith University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuao","family":"Wu","sequence":"additional","affiliation":[{"name":"Griffith University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5553-5270","authenticated-orcid":false,"given":"Matt","family":"Johansen","sequence":"additional","affiliation":[{"name":"School of Life Sciences, University of Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keng","family":"Chew","sequence":"additional","affiliation":[{"name":"School of Chemistry and Molecular Biosciences, The University of Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod","family":"Kumar","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, The University of Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1382-911X","authenticated-orcid":false,"given":"Trent","family":"Woodruff","sequence":"additional","affiliation":[{"name":"University of Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6807-5426","authenticated-orcid":false,"given":"Richard","family":"Clark","sequence":"additional","affiliation":[{"name":"The University of Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Koehbach","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, The University of Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2419-6469","authenticated-orcid":false,"given":"Bruno","family":"Lomonte","sequence":"additional","affiliation":[{"name":"Instituto Clodomiro Picado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Rosado","sequence":"additional","affiliation":[{"name":"Monash University Clayton Campus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merlin","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Central Clinical School, Monash University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2577-710X","authenticated-orcid":false,"given":"Marion","family":"Boudes","sequence":"additional","affiliation":[{"name":"Monash University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyril","family":"Reboul","sequence":"additional","affiliation":[{"name":"Monash University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3616-0279","authenticated-orcid":false,"given":"Lachlan","family":"Rash","sequence":"additional","affiliation":[{"name":"The University of Queensland St Lucia QLD 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Gallo","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, The University of Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumia","family":"Essid","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, The University of Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominika","family":"Elmlund","sequence":"additional","affiliation":[{"name":"Monash Biomedicine Discovery Institute, Monash University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Miemczyk","sequence":"additional","affiliation":[{"name":"University of Technology Sydney"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Hansbro","sequence":"additional","affiliation":[{"name":"University of Technology Sydney"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette","family":"Saunders","sequence":"additional","affiliation":[{"name":"School of Life Sciences, University of Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warwick","family":"Britton","sequence":"additional","affiliation":[{"name":"Centenary Institute, The University of Sydney"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6305-2201","authenticated-orcid":false,"given":"Peter","family":"Sly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaho","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"The University of Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juli\u00e1n","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Instituto Clodomiro Picado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9247-681X","authenticated-orcid":false,"given":"Peter","family":"Moyle","sequence":"additional","affiliation":[{"name":"The University of Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsty","family":"Short","sequence":"additional","affiliation":[{"name":"University of Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Hansbro","sequence":"additional","affiliation":[{"name":"Centenary Institute and University of Technology Sydney"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjaya","family":"Kuruppu","sequence":"additional","affiliation":[{"name":"Monash University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Smith","sequence":"additional","affiliation":[{"name":"Monash University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niwanthi","family":"Rajapakse","sequence":"additional","affiliation":[{"name":"The University of Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/256294","author":"Tikellis C","year":"2012","unstructured":"Tikellis, C. & Thomas, M. C. Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease. Int J Pept 2012, 256294 (2012). https:\/\/doi.org:10.1155\/2012\/256294"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1124\/jpet.122.001339","article-title":"Is Diminazene an Angiotensin-Converting Enzyme 2 (ACE2) Activator? Experimental Evidence and Implications","volume":"383","author":"Esfahani SH","year":"2022","unstructured":"Esfahani, S. H., Jayaraman, S. & Karamyan, V. T. Is Diminazene an Angiotensin-Converting Enzyme 2 (ACE2) Activator? Experimental Evidence and Implications. J Pharmacol Exp Ther 383, 149\u2013156 (2022). https:\/\/doi.org:10.1124\/jpet.122.001339","journal-title":"J Pharmacol Exp Ther"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"22413","DOI":"10.1038\/srep22413","article-title":"N-terminal domain of Bothrops asper Myotoxin II Enhances the Activity of Endothelin Converting Enzyme-1 and Neprilysin","volume":"6","author":"Smith AI","year":"2016","unstructured":"Smith, A. I. et al. N-terminal domain of Bothrops asper Myotoxin II Enhances the Activity of Endothelin Converting Enzyme-1 and Neprilysin. Sci Rep 6, 22413 (2016). https:\/\/doi.org:10.1038\/srep22413","journal-title":"Sci Rep"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan J","year":"2020","unstructured":"Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215\u2013220 (2020). https:\/\/doi.org:10.1038\/s41586-020-2180-5","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.str.2016.07.021","article-title":"Fully Blind Docking at the Atomic Level for Protein-Peptide Complex Structure Prediction","volume":"24","author":"Yan C","year":"2016","unstructured":"Yan, C., Xu, X. & Zou, X. Fully Blind Docking at the Atomic Level for Protein-Peptide Complex Structure Prediction. Structure 24, 1842\u20131853 (2016). https:\/\/doi.org:10.1016\/j.str.2016.07.021","journal-title":"Structure"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1021\/ja026939x","article-title":"HADDOCK: a protein-protein docking approach based on biochemical or biophysical information","volume":"125","author":"Dominguez C","year":"2003","unstructured":"Dominguez, C., Boelens, R. & Bonvin, A. M. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc 125, 1731\u20131737 (2003). https:\/\/doi.org:10.1021\/ja026939x","journal-title":"J Am Chem Soc"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jmb.2015.09.014","article-title":"The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes","volume":"428","author":"Zundert GCP","year":"2016","unstructured":"van Zundert, G. C. P. et al. The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes. J Mol Biol 428, 720\u2013725 (2016). https:\/\/doi.org:10.1016\/j.jmb.2015.09.014","journal-title":"J Mol Biol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41586-020-2772-0","article-title":"Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion","volume":"588","author":"Benton DJ","year":"2020","unstructured":"Benton, D. J. et al. Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion. Nature 588, 327\u2013330 (2020). https:\/\/doi.org:10.1038\/s41586-020-2772-0","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/S1473-3099(21)00262-0","article-title":"SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity","volume":"21","author":"Ramanathan M","year":"2021","unstructured":"Ramanathan, M., Ferguson, I. D., Miao, W. & Khavari, P. A. SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. Lancet Infect Dis 21, 1070 (2021). https:\/\/doi.org:10.1016\/S1473-3099(21)00262-0","journal-title":"Lancet Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1001\/jama.2020.8707","article-title":"Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults","volume":"323","author":"Bunyavanich S","year":"2020","unstructured":"Bunyavanich, S., Do, A. & Vicencio, A. Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults. JAMA 323, 2427\u20132429 (2020). https:\/\/doi.org:10.1001\/jama.2020.8707","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1001\/jama.2020.8946","article-title":"Nasal ACE2 Levels and COVID-19 in Children","volume":"323","author":"Patel AB","year":"2020","unstructured":"Patel, A. B. & Verma, A. Nasal ACE2 Levels and COVID-19 in Children. JAMA 323, 2386\u20132387 (2020). https:\/\/doi.org:10.1001\/jama.2020.8946","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41385-020-00340-z","article-title":"Animal and translational models of SARS-CoV-2 infection and COVID-19","volume":"13","author":"Johansen MD","year":"2020","unstructured":"Johansen, M. D. et al. Animal and translational models of SARS-CoV-2 infection and COVID-19. Mucosal Immunol 13, 877\u2013891 (2020). https:\/\/doi.org:10.1038\/s41385-020-00340-z","journal-title":"Mucosal Immunol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","article-title":"SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function","volume":"21","author":"Winkler ES","year":"2020","unstructured":"Winkler, E. S. et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat Immunol 21, 1327\u20131335 (2020). https:\/\/doi.org:10.1038\/s41590-020-0778-2","journal-title":"Nat Immunol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"629933","DOI":"10.3389\/fcvm.2020.629933","article-title":"Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System","volume":"7","author":"Roberts J","year":"2020","unstructured":"Roberts, J. et al. Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System. Front Cardiovasc Med 7, 629933 (2020). https:\/\/doi.org:10.3389\/fcvm.2020.629933","journal-title":"Front Cardiovasc Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3892\/ijmm.2014.1917","article-title":"The angiotensin-converting enzyme 2\/angiotensin (1\u20137)\/Mas axis protects the function of pancreatic beta cells by improving the function of islet microvascular endothelial cells","volume":"34","author":"Lu CL","year":"2014","unstructured":"Lu, C. L., Wang, Y., Yuan, L., Li, Y. & Li, X. Y. The angiotensin-converting enzyme 2\/angiotensin (1\u20137)\/Mas axis protects the function of pancreatic beta cells by improving the function of islet microvascular endothelial cells. Int J Mol Med 34, 1293\u20131300 (2014). https:\/\/doi.org:10.3892\/ijmm.2014.1917","journal-title":"Int J Mol Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s00125-017-4272-9","article-title":"The islet endothelial cell: a novel contributor to beta cell secretory dysfunction in diabetes","volume":"60","author":"Hogan MF","year":"2017","unstructured":"Hogan, M. F. & Hull, R. L. The islet endothelial cell: a novel contributor to beta cell secretory dysfunction in diabetes. Diabetologia 60, 952\u2013959 (2017). https:\/\/doi.org:10.1007\/s00125-017-4272-9","journal-title":"Diabetologia"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41574-020-00435-4","article-title":"COVID-19 and diabetes mellitus: from pathophysiology to clinical management","volume":"17","author":"Lim S","year":"2021","unstructured":"Lim, S., Bae, J. H., Kwon, H. S. & Nauck, M. A. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol 17, 11\u201330 (2021). https:\/\/doi.org:10.1038\/s41574-020-00435-4","journal-title":"Nat Rev Endocrinol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni W","year":"2020","unstructured":"Ni, W. et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care 24, 422 (2020). https:\/\/doi.org:10.1186\/s13054-020-03120-0","journal-title":"Crit Care"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1056\/NEJMe2103108","article-title":"Interleukin-6 Receptor Inhibition in Covid-19 - Cooling the Inflammatory Soup","volume":"384","author":"Rubin EJ","year":"2021","unstructured":"Rubin, E. J., Longo, D. L. & Baden, L. R. Interleukin-6 Receptor Inhibition in Covid-19 - Cooling the Inflammatory Soup. N Engl J Med 384, 1564\u20131565 (2021). https:\/\/doi.org:10.1056\/NEJMe2103108","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.21037\/atm.2016.12.74","article-title":"IL-6 and type 1 diabetes mellitus: T cell responses and increase in IL-6 receptor surface expression","volume":"5","author":"Gomes KB","year":"2017","unstructured":"Gomes, K. B. IL-6 and type 1 diabetes mellitus: T cell responses and increase in IL-6 receptor surface expression. Ann Transl Med 5, 16 (2017). https:\/\/doi.org:10.21037\/atm.2016.12.74","journal-title":"Ann Transl Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12890-020-01343-z","article-title":"Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome","volume":"20","author":"Pandolfi L","year":"2020","unstructured":"Pandolfi, L. et al. Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome. BMC Pulm Med 20, 301 (2020). https:\/\/doi.org:10.1186\/s12890-020-01343-z","journal-title":"BMC Pulm Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.11.025","author":"Karki R","year":"2021","unstructured":"Karki, R. et al. Synergism of TNF-alpha and IFN-gamma Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes. Cell 184, 149\u2013168 e117 (2021). https:\/\/doi.org:10.1016\/j.cell.2020.11.025"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian A","year":"2021","unstructured":"Nalbandian, A. et al. Post-acute COVID-19 syndrome. Nat Med 27, 601\u2013615 (2021). https:\/\/doi.org:10.1038\/s41591-021-01283-z","journal-title":"Nat Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41586-021-03475-6","article-title":"The spatial landscape of lung pathology during COVID-19 progression","volume":"593","author":"Rendeiro AF","year":"2021","unstructured":"Rendeiro, A. F. et al. The spatial landscape of lung pathology during COVID-19 progression. Nature 593, 564\u2013569 (2021). https:\/\/doi.org:10.1038\/s41586-021-03475-6","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abg9873","article-title":"Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19","volume":"6","author":"Thwaites RS","year":"2021","unstructured":"Thwaites, R. S. et al. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19. Sci Immunol 6 (2021). https:\/\/doi.org:10.1126\/sciimmunol.abg9873","journal-title":"Sci Immunol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.numecd.2022.01.029","article-title":"Type 1 diabetes is associated with significant changes of ACE and ACE2 expression in peripheral blood mononuclear cells","volume":"32","author":"Tonon F","year":"2022","unstructured":"Tonon, F. et al. Type 1 diabetes is associated with significant changes of ACE and ACE2 expression in peripheral blood mononuclear cells. Nutr Metab Cardiovasc Dis 32, 1275\u20131282 (2022). https:\/\/doi.org:10.1016\/j.numecd.2022.01.029","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1021\/acsomega.9b03735","article-title":"Preclinical Pharmacokinetics of Complement C5a Receptor Antagonists PMX53 and PMX205 in Mice","volume":"5","author":"Kumar V","year":"2020","unstructured":"Kumar, V. et al. Preclinical Pharmacokinetics of Complement C5a Receptor Antagonists PMX53 and PMX205 in Mice. ACS Omega 5, 2345\u20132354 (2020). https:\/\/doi.org:10.1021\/acsomega.9b03735","journal-title":"ACS Omega"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"8101","DOI":"10.1038\/s41598-018-26387-4","article-title":"Development and validation of a LC-MS\/MS assay for pharmacokinetic studies of complement C5a receptor antagonists PMX53 and PMX205 in mice","volume":"8","author":"Kumar V","year":"2018","unstructured":"Kumar, V., Lee, J. D., Clark, R. J. & Woodruff, T. M. Development and validation of a LC-MS\/MS assay for pharmacokinetic studies of complement C5a receptor antagonists PMX53 and PMX205 in mice. Sci Rep 8, 8101 (2018). https:\/\/doi.org:10.1038\/s41598-018-26387-4","journal-title":"Sci Rep"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon DE","year":"2020","unstructured":"Gordon, D. E. et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583, 459\u2013468 (2020). https:\/\/doi.org:10.1038\/s41586-020-2286-9","journal-title":"Nature"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41594-020-00549-3","article-title":"A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent","volume":"28","author":"Xiao T","year":"2021","unstructured":"Xiao, T. et al. A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent. Nat Struct Mol Biol 28, 202\u2013209 (2021). https:\/\/doi.org:10.1038\/s41594-020-00549-3","journal-title":"Nat Struct Mol Biol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9416419","author":"Noshahr ZS","year":"2020","unstructured":"Noshahr, Z. S., Salmani, H., Khajavi Rad, A. & Sahebkar, A. Animal Models of Diabetes-Associated Renal Injury. J Diabetes Res 2020, 9416419 (2020). https:\/\/doi.org:10.1155\/2020\/9416419"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/sj.ki.5002373","article-title":"ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice","volume":"72","author":"Soler MJ","year":"2007","unstructured":"Soler, M. J. et al. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int 72, 614\u2013623 (2007). https:\/\/doi.org:10.1038\/sj.ki.5002373","journal-title":"Kidney Int"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e2101316","DOI":"10.1002\/adbi.202101316","article-title":"Atherothrombosis-on-Chip: A Site-Specific Microfluidic Model for Thrombus Formation and Drug Discovery","volume":"6","author":"Akther F","year":"2022","unstructured":"Akther, F. et al. Atherothrombosis-on-Chip: A Site-Specific Microfluidic Model for Thrombus Formation and Drug Discovery. Adv Biol (Weinh) 6, e2101316 (2022). https:\/\/doi.org:10.1002\/adbi.202101316","journal-title":"Adv Biol (Weinh)"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2642181\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2642181\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T16:57:59Z","timestamp":1682441879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2642181\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":33,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2642181\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,4,5]]},"subtype":"preprint"}}